Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2022 Jul 8;15(8):915–921. doi: 10.1016/j.jiph.2022.07.003

The impact of the COVID-19 pandemic in the healthcare utilization in Korea: Analysis of a nationwide survey

EunKyo Kang a,b, Jieun Yun c, Soo-Hee Hwang d, Hyejin Lee e,f,⁎,1, Jin Yong Lee d,g,h,⁎⁎,1
PMCID: PMC9265238  PMID: 35872432

Abstract

Background

COVID-19 has brought changes in daily life and increased the medical burden. This study aims to evaluate the delays in healthcare services and related factors in the general population during the COVID-19 pandemic.

Methods

We took a nationally representative sample and conducted a mobile phone-based survey. The study was conducted anonymously. Of the 3377 subjects who consented to participate, a total of 2097 finished the survey. The primary outcome was respondents’ experiences with delayed (1) health screenings, (2) non-urgent medical visits, (3) medical visits for chronic disease, and (4) emergency visits during the COVID-19 pandemic.

Results

Of 2097 respondents, females, residents of the Seoul metropolitan area, those with private insurance, those without chronic diseases, smokers, and drinkers had higher risk of delays in health screening and non-urgent medical visits after adjustment. Among chronic disease patients, those who were over 60 years old (adjusted odds ratio 0.36, 95% CI 0.14–0.92) showed lower risk of delayed medical visit. Residents of the Seoul metropolitan area, those with private insurance, smokers, and drinkers were all associated with experiencing delayed health screening and non-urgent medical visits had higher risk of delays in chronic disease visits and emergent medical visits.

Conclusions

Delayed access to healthcare services is associated with poor outcomes and may cause different complications. Efforts are needed to prevent delays in medical use due to infectious diseases such as COVID-19. Considering the possibility of the emergence of infectious diseases, various countermeasures are needed to prevent delays in medical visit.

Keywords: SARS-CoV-2, COVID-19, Healthcare utilization, Screening, Korea

Introduction

COVID-19 has brought changes in daily life such as stay-at-home orders and social distancing, and changes in the method of providing healthcare services such as non-face-to-face treatment [1], [2], [3]. In addition, COVID-19 has increased the medical burden, preventing sufficient healthcare services from being provided [4], [5]. Declines in health care services have been reported in a variety of areas, particularly during the COVID-19 pandemic as non-emergency care has been reported [6]. Health screening, including cancer screening [7], and healthcare utilization for the chronic disease were decrease, and the number of cases in which patients choose to take over-the-counter drugs instead of visiting a hospital has increased [8].

This disruption in health care provision is thought to have had a major impact on the care of acute non-COVID-19 conditions, routine treatment of chronic diseases, and early diagnosis and treatment of life-threatening diseases [9], [10]. The healthcare burden caused by COVID-19 can impair the functioning of all medical staff [11], [12], and may limit the use of healthcare for the entire population [13]. However, although COVID-19 may have a significant impact on healthcare utilization in the general population, early studies focused on the impact of COVID-19 on the healthcare utilization of infected patients, such as hospitalizations or ICU admissions [14], [15], [16]. Most previous studies investigated only on restrictions on the healthcare utilization of specific population groups [17], [18], [19]. Although there were studies on general population, most of the studies are on specific situations such as specific screening or emergency care [20], [21], [22].

In the context of pandemic, it is important to understand healthcare resources and access for the general population. This study aims to evaluate the delays in healthcare services and related factors in the general population during the COVID-19 pandemic. Healthcare utilization was evaluated by dividing it into health screening, non-emergency care, chronic disease, and emergency care.

Materials and methods

Participants

The Korean National Statistical Office conducts a census every year. We calculated the representative sample size based on the 2020 National Statistical Office census results, the survey year. Assuming a 95% confidence interval, 2.2% error margin, and 0.5% standard deviation, the estimated sample size was 1984 people. Considering that some questions may not be answered, we collected more than 3000 participants. For the study subjects, sampling was conducted using quota samples by age, gender, and region for residents aged 19 years or older residing in Korea. For the sampling, in the first step according to the population structure of the 2015 Population census of the National Statistical Office, an appropriate number of samples was allocated according to the population distribution of 16 administrative districts. All 16 administrative districts were included in the sampling. The number of subjects by age and gender was earmarked for each organizational district unit in the second step.

An anonymous, voluntary web-based survey was accomplished by participants recruited from November 9 to December 4. Participants interested in the study were enrolled after confirming whether they met the inclusion criteria, and respondents who finally completed the survey were included in the study. The study inclusion criteria were those 19 years of age or older, physically healthy, and mentally stable enough to read, understand, and answer the questionnaire. Those who do not understand Korean proficiently may have limitations in understanding the consent form or reading and answering questions, so they were excluded from the study. The study protocol was approved by the Institutional Review Board (IRB no. E-2011–102–1173).

Survey design

This study was conducted in all regions of Korea with technical assistance from a social research company (Gallup Korea). The survey was pilot-tested with 100 respondents to identify unclear instructions or questions, ambiguous response expression, or other issues with the survey, and revised. Data from pilot tests were not utilized in the analysis of the study. Based on the revised survey, the research subjects were informed of the purpose of the study, consented to participate, and then went to an encrypted website and filled out a questionnaire.

The study was conducted anonymously, but to prevent duplicate responses to the questionnaire, the study subjects were asked to use a mobile phone authentication system. When a respondent enters their mobile phone number, a password is sent to their mobile phone. The password is used to identify the mobile phone owner based on information from the mobile network provider, thereby preventing duplicate surveys. The questionnaire in this study was constructed in a multiple-choice format, and if a response is omitted, it is impossible to move to the next page. For this reason, there were no missing values in the case of respondents who completed the survey. When a study participant gave the same or similar answer to a question on one page (10 questions), a pop-up was set up to confirm the answer. Of the 3377 subjects who consented to participate, a total of 2097 finished the survey, and the dropout rate was 37.9%.

Outcome measure

The primary outcome was respondents’ experiences with delayed (1) health screenings, (2) non-urgent medical visits, (3) medical visits for chronic disease, and (4) emergency visits during the COVID-19 pandemic. The questionnaire included questions about the demographic characteristics of the respondents, having chronic diseases, smoking and drinking habits, and the primary outcome. Demographic characteristics included gender, age, region of residence, marital status, occupation, education status, the poverty-income ratio, and private insurance status. In Korea, there were large-scale COVID-19 outbreaks in the Seoul metropolitan area and Daegu and Gyeongbuk areas, with fewer cases in other areas. Therefore, we divided the region of residence into three regions. To investigate whether they had a chronic disease, respondents were asked about their disease and duration of treatment.

Respondents with diseases such as heart disease, cancer, or diabetes that lasted more than 1 year and required continuous treatment or had limited activity were coded as chronic diseases. Smoking and alcohol consumption assessments included self-reported smoking and alcohol consumption.

Statistical analysis

We performed descriptive statistics on respondents’ demographics. Numerical data were presented as numbers and percentages. Univariate and multivariate logistic regression were used to calculate the crude and adjusted odds ratio (aOR) with 95% confident interval (CI), and logistic regression was used to analyze the correlation between potential risk factors related to delay in healthcare utilization. A P value of< 0.05 indicates statistical significance. All statistical analyzes were conducted using R Statistical Software, version 4.0.2 (R Foundation for Statistical Computing, Vienna, Austria).

Results

Baseline characteristics of the respondents

A summary of the respondents’ demographics and characteristics is represented in Table 1. Two thousand ninety-seven individuals who completed the survey were included in the analysis. The proportion of men and women who responded in the survey was similar (50.5% vs. 49.6%). As for the residential regions, 19.1% were in the metropolitan area and 9.4% were in Daegu and Gyeongbuk area. Among the respondents, 59.7% were married, 52.9% were office workers, and 71.4% had a college, university graduation, or associate degree. The poverty-income ratio of 1.0–2.0 was 45.8%, accounting for the majority. Of the total, 81.9% had private insurance, 48.5% reported having a chronic disease, 26.0% smoked, and 76.4% drank alcohol.

Table 1.

Baseline characteristics of the respondents and ratio of experienced delays for health screening and non-urgent medical visits.

Total Delays in health screening
(N = 2097)
Delays in non-urgent medical visits (Elective and non-chronic conditions) (N = 2097)
Yes, No (%) No, No (%) p-value Yes, No (%) No, No (%) p-value
540 (25.8) 1557 (74.2) 159 (7.6) 1938 (92.4)
Sex
Male 1058 (50.5) 226 (21.4) 832 (78.6) < 0.001 67 (6.3) 991 (93.7) 0.03
Female 1039 (49.6) 314 (30.2) 725 (69.8) 92 (8.9) 947 (91.2)
Age
19–29 377 (18.0) 71 (18.8) 306 (81.2) 0.07 29 (7.7) 348 (92.3) 0.07
30–39 411 (19.6) 104 (25.3) 307 (74.7) 41 (10.0) 370 (90.0)
40–49 485 (23.1) 152 (31.3) 333 (68.7) 40 (8.3) 445 (91.8)
50–59 479 (22.8) 130 (27.1) 349 (72.9) 28 (5.9) 451 (94.2)
≥ 60 345 (16.5) 83 (24.1) 262 (75.9) 21 (6.1) 324 (93.9)
Region
Seoul metropolitan area 401 (19.1) 125 (31.2) 276 (68.8) 0.022 39 (9.7) 362 (90.3) 0.19
Daegu-Gyeongbuk area 196 (9.4) 48 (24.5) 148 (75.5) 13 (6.6) 183 (93.4)
Others 1500 (71.5) 367 (24.5) 1133 (75.5) 107 (7.1) 1393 (92.9)
Marital status
Single 755 (36.0) 157 (20.8) 598 (79.2) 0.001 51 (6.8) 704 (93.3) 0.34
Married 1251 (59.7) 361 (28.9) 890 (71.1) 101 (8.1) 1150 (91.9)
Widowed/divorced 91 (4.3) 22 (24.2) 69 (75.8) 7 (7.7) 84 (92.3)
Job status
Own business 193 (9.2) 36 (18.7) 157 (81.4) 0.03 14 (7.3) 179 (92.8) 0.46
Manual worker 212 (10.1) 44 (20.8) 168 (79.3) 16 (7.6) 196 (92.5)
Office worker 1110 (52.9) 316 (28.5) 794 (71.5) 94 (8.5) 1016 (91.5)
Housewife/Student/Unemployed 582 (27.8) 144 (24.7) 438 (75.3) 35 (6.0) 547 (94.0)
Educational status
High school graduate and under 359 (17.1) 67 (18.7) 292 (81.3) < 0.001 21 (5.9) 338 (94.2) 0.38
College / university graduation or associate degree 1498 (71.4) 395 (26.4) 1103 (73.6) 124 (8.3) 1374 (91.7)
Master’s degree or above 240 (11.4) 78 (32.5) 162 (67.5) 14 (5.8) 226 (94.2)
The poverty-income ratio
0–1.0 863 (41.4) 196 (22.7) 667 (77.3) 0.001 69 (8.0) 794 (92.0) 0.63
1.0–2.0 955 (45.8) 255 (26.7) 700 (73.3) 69 (7.2) 886 (92.8)
≥ 2.0 268 (12.9) 87 (32.5) 181 (67.5) 20 (7.5) 248 (92.5)
Private insurance
Yes 1718 (81.9) 482 (28.1) 1236 (71.9) < 0.001 137 (8.0) 1581 (92.0) 0.15
No 379 (18.1) 58 (15.3) 321 (84.7) 22 (5.8) 357 (94.2)
Chronic diseases
Yes 1016 (48.5) 213 (21.0) 803 (79.0) < 0.001 56 (5.5) 960 (94.5) 0.001
No 1081 (51.6) 327 (30.2) 754 (69.8) 103 (9.5) 978 (90.5)
Smoking
Yes 545 (26.0) 142 (26.1) 403 (73.9) 0.85 57 (10.5) 488 (89.5) 0.003
No 1552 (74.0) 398 (25.6) 1154 (74.4) 102 (6.6) 1450 (93.4)
Alcohol drinking
Yes 1603 (76.4) 447 (27.9) 1156 (72.1) < 0.001 141 (8.8) 1462 (91.2) < 0.001
No 494 (23.6) 93 (18.8) 401 (81.2) 18 (3.6) 476 (96.4)

Factors associated with experiencing delayed health screening and non-urgent medical visits

Respondents with a significantly higher adjusted risk of experiencing delayed health screening were female (aOR 1.85, 95% CI 1.47–2.32), ages 40–49 (aOR 1.71, 95% CI 1.17–2.50), residents of the Seoul metropolitan area (aOR 1.34, 95% CI 1.06–1.69), married (aOR 1.35, 95% CI 1.02–1.79), those with a college/university degree (aOR 1.65, 95% CI 1.20–2.27) or higher (aOR 2.17, 95% CI 1.43–3.30), those with private insurance (aOR 1.82, 95% CI 1.33–2.49), those without chronic disease (aOR 1.62, 95% CI 1.31–2.00), smokers (aOR 1.85, 95% CI 1.47–2.32), and alcohol drinkers (aOR 1.71, 95% CI 1.31–2.24). Table 2, Table 3, Table 4.

Table 2.

Crude and adjusted odds ratio from logistic regression analysis of factors associated with delays in health screening and non-urgent medical visits.

Delays in health screening
(N = 2097)
Delays in non-urgent medical visits (Elective and non-chronic conditions) (N = 2097)
Sex Crude OR Adjusted OR Crude OR Adjusted OR
Male 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
Female 1.59 (1.31–1.94) 1.85 (1.47–2.32) 1.44 (1.04–1.99) 2.17 (1.49–3.16)
Age
19–29 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
30–39 1.46 (1.04–2.05) 1.31 (0.90–1.89) 1.33 (0.81–2.19) 0.98 (0.56–1.73)
40–49 1.97 (1.43–2.71) 1.71 (1.17–2.50) 1.08 (0.66–1.78) 0.70 (0.38–1.29)
50–59 1.61 (1.16–2.23) 1.47 (0.98–2.21) 0.75 (0.44–1.28) 0.48 (0.24–0.94)
≥ 60 1.37 (0.96–1.95) 1.23 (0.78–1.92) 0.78 (0.43–1.39) 0.50 (0.24–1.05)
Region
Seoul metropolitan area 1.40 (1.10–1.78) 1.34 (1.06–1.69) 1.45 (0.98–2.14) 1.75 (1.18–2.60)
Daegu-Gyeongbuk area 1.00 (0.71–1.42) 1.00 (0.73–1.36) 0.93 (0.51–1.68) 0.91 (0.50–1.68)
Others 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
Marital status
Single 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
Married 1.54 (1.25–1.91) 1.35 (1.02–1.79) 1.21 (0.85–1.72) 1.52 (0.96–2.42)
Widowed/divorced 1.21 (0.73–2.02) 1.26 (0.71–2.25) 1.15 (0.51–2.62) 1.53 (0.61–3.82)
Job status
Own business 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
Manual worker 1.14 (0.70–1.87) 1.24 (0.74–2.07) 1.04 (0.50–2.20) 0.89 (0.41–1.94)
Office worker 1.74 (1.18–2.55) 1.48 (0.98–2.22) 1.18 (0.66–2.12) 0.90 (0.48–1.68)
Housewife/Student/Unemployed 1.43 (0.95–2.16) 1.46 (0.95–2.25) 0.82 (0.43–1.56) 0.73 (0.37–1.44)
Educational status
High school graduate and under 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
College / university graduation or associate degree 1.56 (1.17–2.08) 1.65 (1.20–2.27) 1.45 (0.90–2.34) 1.41 (0.84–2.37)
Master’s degree or above 2.10 (1.44–3.06) 2.17 (1.43–3.30) 1.00 (0.50–2.00) 0.99 (0.47–2.10)
The poverty-income ratio
0–1.0 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
1.0–2.0 1.24 (1.00–1.54) 1.03 (0.82–1.29) 0.90 (0.63–1.27) 0.76 (0.52–1.09)
≥ 2.0 1.64 (1.21–2.21) 1.24 (0.89–1.71) 0.93 (0.55–1.56) 0.72 (0.41–1.25)
Private insurance
Yes 2.16 (1.60–2.91) 1.82 (1.33–2.49) 1.41 (0.88–2.24) 1.49 (1.06–2.09)
No 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
Chronic diseases
Yes 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
No 1.63 (1.34–2.00) 1.62 (1.31–2.00) 1.81 (1.29–2.53) 1.88 (1.32–2.68)
Smoking
Yes 1.02 (0.82–1.28) 1.85 (1.47–2.32) 1.66 (1.18–2.33) 2.20 (1.31–3.72)
No 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
Alcohol drinking
Yes 1.67 (1.30–2.14) 1.71 (1.31–2.24) 2.55 (1.54–4.21) 1.71 (1.15–2.54)
No 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)

Table 3.

Crude and adjusted odds ratio of factors associated with delays in medical visits for chronic diseases.

Total, No (%) Yes, No (%) Crude OR Adjusted OR
Total 1081 108 (10.0)
Sex
Male 585 (54.1) 60 (10.3) 1 (Ref) 1 (Ref)
Female 496 (45.9) 48 (9.7) 0.94 (0.63–1.40) 1.45 (0.91–2.33)
Age
19–29 153 (14.2) 20 (13.1) 1 (Ref) 1 (Ref)
30–39 185 (17.1) 23 (12.4) 0.94 (0.50–1.79) 0.79 (0.38–1.65)
40–49 234 (21.7) 29 (12.4) 0.94 (0.51–1.73) 0.66 (0.31–1.42)
50–59 269 (24.9) 23 (8.6) 0.62 (0.33–1.17) 0.51 (0.22–1.16)
≥ 60 240 (22.2) 13 (5.4) 0.38 (0.18–0.79) 0.36 (0.14–0.92)
Region
Seoul metropolitan area 232 (21.5) 31 (13.4) 1.57 (1.01–2.47) 1.64 (1.02–2.69)
Daegu-Gyeongbuk area 100 (9.3) 10 (10.0) 1.13 (0.56–2.28) 1.26 (0.61–2.61)
Others 749 (69.3) 67 (9.0) 1 (Ref) 1 (Ref)
Marital status
Single 319 (29.5) 35 (11.0) 1 (Ref) 1 (Ref)
Married 704 (65.1) 72 (10.2) 0.92 (0.60–1.42) 1.27 (0.71–2.26)
Widowed/divorced 58 (5.4) 1 (1.7) 0.14 (0.02–1.06) 0.20 (0.03–1.62)
Job status
Own business 105 (9.7) 7 (6.7) 1 (Ref) 1 (Ref)
Manual worker 120 (11.1) 18 (15.0) 2.47 (1.02–6.17) 2.01 (0.76–5.31)
Office worker 564 (52.2) 64 (11.4) 1.79 (0.80–4.03) 1.22 (0.51–2.91)
Housewife/Student/
Unemployed 292 (27.0) 19 (6.5) 0.97 (0.40–2.39) 0.84 (0.32–2.20)
Educational status
High school graduate and under 199 (18.4) 20 (10.1) 1 (Ref) 1 (Ref)
College / university graduation 737 (68.2) 79 (10.7) 1.07 (0.64–1.80) 0.81 (0.45–1.46)
Master’s degree or above 145 (13.4) 9 (6.2) 0.59 (0.26–1.34) 0.46 (0.19–0.87)
The poverty-income ratio
0–1.0 450 (41.9) 47 (10.4) 1 (Ref) 1 (Ref)
1.0–2.0 487 (45.3) 43 (8.8) 0.83 (0.54–1.28) 0.66 (0.41–1.06)
≥ 2.0 138 (12.8) 16 (11.6) 1.12 (0.62–2.05) 0.89 (0.46–1.72)
Private insurance
Yes 890 (82.3) 99 (11.1) 2.53 (1.26–5.10) 2.15 (1.03–4.51)
No 191 (17.7) 9 (4.7) 1 (Ref) 1 (Ref)
Smoking
Yes 329 (30.4) 53 (16.1) 2.43 (1.63–3.64) 2.25 (1.39–3.63)
No 752 (69.6) 55 (7.3) 1 (Ref) 1 (Ref)
Alcohol drinking
Yes 834 (77.2) 97 (11.6) 2.82 (1.49–5.36) 2.01 (1.03–3.94)
No 247 (22.9) 11 (4.5) 1 (Ref) 1 (Ref)

Table 4.

Crude and adjusted odds ratio of factors associated with delays in emergent medical visits.

Total, No (%) Yes, No (%) Crude OR Adjusted OR
Total 139 55 (39.6)
Sex
Male 68 (48.9) 31 (45.6) 1 (Ref) 1 (Ref)
Female 71 (51.1) 24 (33.8) 0.61 (0.31–1.21) 1.00 (0.40–2.46)
Age
19–29 28 (20.1) 11 (39.3) 1 (Ref) 1 (Ref)
30–39 32 (23.0) 17 (53.1) 1.75 (0.63–4.90) 1.18 (0.30–4.72)
40–49 34 (24.5) 12 (35.3) 0.84 (0.30–2.37) 0.66 (0.14–3.09)
50–59 24 (17.3) 5 (20.8) 0.41 (0.12–1.41) 0.43 (0.08–2.45)
≥ 60 21 (15.1) 10 (47.6) 1.40 (0.45–4.41) 1.60 (0.28–9.22)
Region
Seoul metropolitan area 36 (25.9) 19 (52.8) 2.06 (0.94–4.51) 2.76 (1.37–4.65)
Daegu-Gyeongbuk area 12 (8.6) 4 (33.3) 0.92 (0.26–3.30) 0.68 (0.15–3.01)
Others 91 (65.5) 32 (35.2) 1 (Ref) 1 (Ref)
Marital status
Single 40 (28.8) 13 (32.5) 1 (Ref) 1 (Ref)
Married 94 (67.6) 41 (43.6) 1.61 (0.74–3.49) 2.10 (0.74–5.98)
Widowed/divorced 5 (3.6) 1 (20.0) 0.52 (0.05–5.12) 1.05 (0.06–17.81)
Job status
Own business 10 (7.2) 6 (60.0) 1 (Ref) 1 (Ref)
Manual worker 16 (11.5) 6 (37.5) 0.40 (0.08–2.02) 0.21 (0.03–1.47)
Office worker 82 (59.0) 36 (43.9) 0.52 (0.14–1.99) 0.30 (0.06–1.62)
Housewife/Student/
Unemployed
31 (22.3) 7 (22.6) 0.19 (0.04–0.89) 0.23 (0.04–0.81)
Educational status
High school graduate and under 15 (10.8) 5 (33.3) 1 (Ref) 1 (Ref)
College / university graduation 110 (79.1) 43 (39.1) 1.28 (0.41–4.01) 1.38 (0.39–4.96)
Master’s degree or above 14 (10.1) 7 (50.0) 2.00 (0.45–8.96) 2.27 (0.43–12.07)
The poverty-income ratio
0–1.0 51 (37.2) 22 (43.1) 1 (Ref) 1 (Ref)
1.0–2.0 66 (48.2) 23 (34.9) 0.71 (0.33–1.49) 0.59 (0.24–1.44)
≥ 2.0 20 (14.6) 9 (45.0) 1.08 (0.38–3.05) 0.99 (0.28–3.44)
Private insurance
Yes 123 (88.5) 51 (41.5) 0.47 (0.14–1.54) 0.13 (0.03–0.62)
No 16 (11.5) 4 (25.0) 1 (Ref) 1 (Ref)
Smoking
Yes 55 (39.6) 32 (58.2) 3.69 (1.80–7.57) 3.08 (1.36–6.96)
No 84 (60.4) 23 (27.4) 1 (Ref) 1 (Ref)
Alcohol drinking
Yes 119 (85.6) 53 (44.5) 7.23 (1.60–32.55) 5.35 (2.07–26.70)
No 20 (14.4) 2 (10.0) 1 (Ref) 1 (Ref)

Respondents with a significantly higher adjusted risk of experiencing delayed health screening were female (aOR 2.17, 95% CI 1.49–3.16), residents of the Seoul metropolitan area (aOR 1.75, 95% CI 1.18–2.60), those with private insurance (aOR 1.49, 95% CI 1.06–2.09), those without chronic disease (aOR 1.88, 95% CI 1.32–2.68), smokers (aOR 2.20, 95% CI 1.31–3.72), and alcohol drinkers (aOR 1.71, 95% CI 1.15–2.54). For respondents in the age group of 50–59 years, aOR to experience delays in non-urgent medical visits was significantly lower (aOR 0.48, 95% CI 0.24–0.94).

Factors associated with experiencing delayed medical visits for chronic disease

Factors related to delay in medical visits due to chronic diseases were investigated for 1081 individuals who answered that they had chronic diseases. Among chronic disease patients, 10% of the respondents answered that they had experienced delays in medical visits due to chronic diseases, and the following factors showed a significant correlation; those who were over 60 years old (aOR 0.36, 95% CI 0.14–0.92), residents of the Seoul metropolitan area (aOR 1.64, 95% CI 1.02–2.69), those with a master’s degree or above (aOR 0.46, 95% CI 0.19–0.87), those with private insurance (aOR 2.15, 95% CI 1.03–4.51), smokers (aOR 2.25, 95% CI 1.39–3.63), and alcohol drinkers (aOR 2.01, 95% CI 1.03–3.94).

Factors associated with experiencing delayed emergent medical visits

One hundred thirty-nine patients visited the emergency room during the COVID-19 epidemic, accounting for about 6.6% of the total respondents. Of the 139 respondents, 55 (39.6%) answered that they experienced delay in emergent medical visits, and the following factors were related to the experience of delay; residents of the Seoul metropolitan area (aOR 2.76, 95% CI 1.37–4.65), those were housewife/student/unemployed (aOR 0.23, 95% CI 0.04–0.81), those with private insurance (aOR 0.13, 95% CI 0.03–0.62), smokers (aOR 3.08, 95% CI 1.36–6.96), and alcohol drinkers (aOR 5.35, 95% CI 2.07–26.70).

Discussion

Females, residents of the Seoul metropolitan region, one of the COVID-19 epidemic zones, those with private insurance, those without chronic diseases, smokers, and drinkers were all associated with experiencing delayed health screening and non-urgent medical visits. Among chronic disease patients, Age over 60 was negatively associated with delayed medical visits for chronic diseases. People who live in areas where COVID-19 is pandemic, such as Seoul metropolitan area, have been associated with delays in health screening, non-urgent medical visits, medical visits due to chronic diseases and delays in emergent medical visits. In the case of highly educated people, there was a significantly negative correlation with the experience of delayed medical visits for chronic diseases. The respondents with private insurance were significantly associated with delayed visits for chronic diseases, and conversely, less risk of delays for emergency visits. Smoking and alcohol drinking also positively correlated with delays in health screening, non-urgent medical visits, medical visits for chronic diseases and emergency medical visits.

It has already been reported that restricting or avoiding access to medical care significantly impacts the occurrence and worsening of diseases and complications [23], [24], timely provision and high access to medical care are essential for health outcomes, prognosis, well-being, avoidable hospitalization, and disease prevention [25], [26]. Whatever the reasons for experiencing delayed medical visits during this pandemic, there is concern that these delays would result in increase in morbidity and mortality over the next following months or years [10], [27], [28], [29]. Delays in screenings or non-urgent medical visits may reduce the rate of early disease detection, and patients with chronic diseases are more likely to experience severe complications if treatment is delayed or discontinued [29], [30], [31]. Several studies reported that reductions in cancer screening have a considerable impact on cancer incidence and prognosis [19], [22], [30]. A study that simulated the interruption of colorectal cancer screening programs worldwide during the COVID-19 pandemic found that even if screening is reduced or stopped for only six months, colorectal cancer deaths may increase by 0.4–1.0% for 30 years to 2050 [7]. In case of emergency or severe diseases, more critical problems may occur [32]. In previous studies, emergent medical visits for non-COVID-19 also decreased significantly [33], [34]. According to Metzler et al.[35], due to the COVID-19 pandemic, approximately 40% of patients with acute coronary syndrome did not receive treatment, and 40% of those who did not receive treatment experienced severe complications or death.

This study found that the Seoul metropolitan area, a COVID-19 hotspots, was more likely to experience delays in all medical visits. This seems to be due to differences in social distancing policies and anxiety about COVID-19 infection by region. The Korean central government provided a guide to take customized actions for each region according to the scale and rate of transmission. When COVID-19 was prevalent only in some regions, the strength of social distancing has been determined by region [36]. Therefore, the COVID-19 hotspot was in a situation where a relatively strict social distancing policy was applied. Furthermore, there was an outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV) in Korea in 2015, and most cases were hospital-acquired infection [37]. Therefore, it is presumed that Koreans were concerned about infection due to hospital use. Furthermore, in areas where COVID-19 was endemic, medical resources were focused on severe COVID-19 patients. [38]. As a result, it might affect the early diagnosis rate, long-term morbidity, and survival of patients who missed screening or treatment during this period due to unintended consequences. In this study, it was confirmed that not only the medical utilization for specific purposes, but also several healthcare utilizations such as health screenings and non-emergency diseases could all decrease. Several studies also reported a decrease in medical use as in our study, but most of them were limited to specific services [21], [22], [23], [25], [28]. Our study has the advantage of being able to confirm changes in overall healthcare utilization.

In our study, delays in medical visits were higher for some types of medical visits and lower for others in highly educated or privately insured people. These are people with a high socioeconomic status (SES); the higher the SES, the more likely they are to have access to health care, even if health care resources are limited [39], [40], [41]. As a result, although the exact cause was not known, it is estimated that these results were contradictory depending on the type of medical service as a result of selective medical use.

Smokers and drinkers were also more likely to significantly delay or decrease the use of healthcare services during COVID-19, including health screenings [42]. Considering that these people have a higher risk of disease than other population groups, health care providers and policymakers should be careful not to delay the use of healthcare services, including health screening [43], [44].

Delayed access to healthcare services is associated with poor outcomes and may cause different complications, especially in the case of chronically ill patients. In our study, people with chronic diseases had a lower risk of delays in health screening, and non-urgent medical visits than those without chronic diseases. However, among those with chronic diseases, 213 (21.0%) experienced delays in health screening, and 56 (5.5%) experienced delays in non-urgent medical visits. Furthermore, 108 (10.0%) of those with chronic diseases experienced a delay in medical visits for chronic diseases. Thus, even if people with chronic diseases had lower risk of delays in health services, efforts are needed to prevent delays in medical use due to infectious diseases such as COVID-19, and some people with chronic diseases may experience health problems as a result of delayed medical services. Considering the possibility of the emergence of infectious diseases, various countermeasures including non-face-to-face treatment are needed to prevent delays in medical visit [3], [45].

The lack of direct and valid measures of an individual’s healthcare utilization is a limitation of the study. However, this study provided insight into factors related to delays in various healthcare services by surveying a representative population of a country.

In conclusion, COVID-19 has changed the general population's access to healthcare, and the degree of change varies with individual characteristics. The changes brought about by COVID-19 require new normal in our society, and it is important to maintain appropriate access to healthcare services even in new situations. The findings of this study will contribute to finding ways to prevent and respond to delay in medical service in epidemic that may occur in the future.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Disclosure

All authors have no potential conflicts of interest.

References

  • 1.Doraiswamy S., Abraham A., Mamtani R., Cheema S. Use of telehealth during the COVID-19 pandemic: scoping review. J Med Internet Res. 2020;22(12) doi: 10.2196/24087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Ohannessian R., Duong T.A., Odone A. Global telemedicine implementation and integration within health systems to fight the COVID-19 pandemic: a Call to Action. JMIR Public Health Surveill. 2020;6(2) doi: 10.2196/18810. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Kim H., Lee H., Park C.S., Kim S., Cho S.A., Yoo S.M., et al. Preliminary results of teleconsultations temporarily allowed during the COVID-19 pandemic. Yonsei Med J. 2021;62(9):850–857. doi: 10.3349/ymj.2021.62.9.850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Schrack J.A., Wanigatunga A.A., Juraschek S.P. After the COVID-19 pandemic: the next wave of health challenges for older adults. J Gerontol A Biol Sci Med Sci. 2020;75(9):e121–e122. doi: 10.1093/gerona/glaa102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Wright A., Salazar A., Mirica M., Volk L.A., Schiff G.D. The invisible epidemic: neglected chronic disease management during COVID-19. J Gen Intern Med. 2020;35(9):2816–2817. doi: 10.1007/s11606-020-06025-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Mehrotra A., Chernew M., Linetsky D., Hatch H., Cutler D., Schneider E.: The impact of COVID-19 on outpatient visits in 2020: visits remained stable, despite a late surge in cases. Commonwealth Fund. February 2021. In.
  • 7.de Jonge L., Worthington J., van Wifferen F., Iragorri N., Peterse E.F.P., Lew J.B., et al. Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study. Lancet Gastroenterol Hepatol. 2021;6(4):304–314. doi: 10.1016/S2468-1253(21)00003-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Lim M.A., Huang I., Yonas E., Vania R., Pranata R. A wave of non-communicable diseases following the COVID-19 pandemic. Diabetes Metab Syndr. 2020;14(5):979–980. doi: 10.1016/j.dsx.2020.06.050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Rosenbaum L. The untold toll - the pandemic’s effects on patients without covid-19. N Engl J Med. 2020;382(24):2368–2371. doi: 10.1056/NEJMms2009984. [DOI] [PubMed] [Google Scholar]
  • 10.Moynihan R., Sanders S., Michaleff Z.A., Scott A.M., Clark J., To E.J., et al. Impact of COVID-19 pandemic on utilisation of healthcare services: a systematic review. BMJ Open. 2021;11(3) doi: 10.1136/bmjopen-2020-045343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Coster S., Watkins M., Norman I.J. What is the impact of professional nursing on patients’ outcomes globally? An overview of research evidence. Int J Nurs Stud. 2018;78:76–83. doi: 10.1016/j.ijnurstu.2017.10.009. [DOI] [PubMed] [Google Scholar]
  • 12.Lee A., Cheung Y.S.L., Joynt G.M., Leung C.C.H., Wong W.T., Gomersall C.D. Are high nurse workload/staffing ratios associated with decreased survival in critically ill patients? A cohort study. Ann Intensive care. 2017;7(1):46. doi: 10.1186/s13613-017-0269-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Weissman G.E., Crane-Droesch A., Chivers C., Luong T., Hanish A., Levy M.Z., et al. Locally informed simulation to predict hospital capacity needs during the COVID-19 pandemic. Ann Intern Med. 2020;173(1):21–28. doi: 10.7326/M20-1260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Elke B., Juliane W., Helene E., Ulrike N., Dimitra P., Christoph R., et al. A country-level analysis comparing hospital capacity and utilisation during the first COVID-19 wave across Europe. Health Policy. 2021 doi: 10.1016/j.healthpol.2021.11.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Gupta S., Hayek S.S., Wang W., Chan L., Mathews K.S., Melamed M.L., et al. Factors associated with death in critically Ill patients with coronavirus disease 2019 in the US. JAMA Intern Med. 2020;180(11):1436–1447. doi: 10.1001/jamainternmed.2020.3596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Emanuel E.J., Persad G., Upshur R., Thome B., Parker M., Glickman A., et al. Fair allocation of scarce medical resources in the time of covid-19. N Engl J Med. 2020;382(21):2049–2055. doi: 10.1056/NEJMsb2005114. [DOI] [PubMed] [Google Scholar]
  • 17.Antonucci M., Recupero S.M., Marzio V., De Dominicis M., Pinto F., Foschi N., et al. The impact of COVID-19 outbreak on urolithiasis emergency department admissions, hospitalizations and clinical management in central Italy: a multicentric analysis. Actas Urol Esp. 2020;44(9):611–616. doi: 10.1016/j.acuro.2020.06.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Nascimento B.R., Brant L.C.C., Castro A.C.T., Froes L.E.V., Ribeiro A.L.P., Teixeira R.A., et al. Reduction in hospital admissions associated with coronary events during the COVID-19 pandemic in the brazilian private health system: data from the UNIMED-BH system. Rev Soc Bras Med Trop. 2021;54 doi: 10.1590/0037-8682-0174-2021. e01742021-e01742021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Mafra da Costa A., Ribeiro A.L., Ribeiro A.G., Gini A., Cabasag C., Reis R.M., et al. Impact of COVID-19 pandemic on cancer-related hospitalizations in Brazil. Cancer Control J Moffitt Cancer Cent. 2021;28 doi: 10.1177/10732748211038736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Bergonti M. Emergency Room visits in the COVID-19 pandemic. Eur Heart J. 2021;42(5):369–370. doi: 10.1093/eurheartj/ehaa938. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Peng S.M., Yang K.C., Chan W.P., Wang Y.W., Lin L.J., Yen A.M., et al. Impact of the COVID-19 pandemic on a population-based breast cancer screening program. Cancer. 2020;126(24):5202–5205. doi: 10.1002/cncr.33180. [DOI] [PubMed] [Google Scholar]
  • 22.Bakouny Z., Paciotti M., Schmidt A.L., Lipsitz S.R., Choueiri T.K., Trinh Q.D. Cancer screening tests and cancer diagnoses during the COVID-19 pandemic. JAMA Oncol. 2021;7(3):458–460. doi: 10.1001/jamaoncol.2020.7600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Lazzerini M., Barbi E., Apicella A., Marchetti F., Cardinale F., Trobia G. Delayed access or provision of care in Italy resulting from fear of COVID-19. Lancet Child Adolesc Health. 2020;4(5):e10–e11. doi: 10.1016/S2352-4642(20)30108-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Huang Y.T., Lee Y.C., Hsiao C.J. Hospitalization for ambulatory-care-sensitive conditions in Taiwan following the SARS outbreak: a population-based interrupted time series study. J Formos Med Assoc Taiwan yi zhi. 2009;108(5):386–394. doi: 10.1016/S0929-6646(09)60082-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Teoh S.E., Masuda Y., Tan D.J.H., Liu N., Morrison L.J., Ong M.E.H., et al. Impact of the COVID-19 pandemic on the epidemiology of out-of-hospital cardiac arrest: a systematic review and meta-analysis. Ann Intensive Care. 2021;11(1):169. doi: 10.1186/s13613-021-00957-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Ishimaru T., Tsuno K., Hori A., Okawara M., Yasuda Y., Fujino Y., et al. Disrupted care during the COVID-19 state of emergency and productivity loss attributed to presenteeism in workers: a nationwide cross-sectional study. BMJ Open. 2021;11(12) doi: 10.1136/bmjopen-2021-050068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Moraliyage H., De Silva D., Ranasinghe W., Adikari A., Alahakoon D., Prasad R., et al. Cancer in lockdown: impact of the COVID-19 pandemic on patients with cancer. oncologist. 2021;26(2):e342–e344. doi: 10.1002/onco.13604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Kiss P., Carcel C., Hockham C., Peters S.A.E. The impact of the COVID-19 pandemic on the care and management of patients with acute cardiovascular disease: a systematic review. Eur Heart J Qual Care Clin Outcomes. 2021;7(1):18–27. doi: 10.1093/ehjqcco/qcaa084. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Marzo-Castillejo M., Guiriguet Capdevila C., Coma, Redon E. The impact of COVID-19 on cancer diagnosis delay: possible consequences. Atencion Prima. 2021;53(9) doi: 10.1016/j.aprim.2021.102142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Vose J.M. Delay in cancer screening and diagnosis during the COVID-19 pandemic: what is the cost? Oncology. 2020;34(9):343. doi: 10.46883/ONC.2020.3409.0343. [DOI] [PubMed] [Google Scholar]
  • 31.Nadar S.K., Tayebjee M.H., Stowasser M., Byrd J.B. Managing hypertension during the COVID-19 pandemic. J Hum Hypertens. 2020;34(6):415–417. doi: 10.1038/s41371-020-0356-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Boukhris M., Hillani A., Moroni F., Annabi M.S., Addad F., Ribeiro M.H., et al. Cardiovascular implications of the COVID-19 pandemic: a global perspective. Can J Cardiol. 2020;36(7):1068–1080. doi: 10.1016/j.cjca.2020.05.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Friedman A.B., Barfield D., David G., Diller T., Gunnarson C., Liu M., et al. Delayed emergencies: the composition and magnitude of non-respiratory emergency department visits during the COVID-19 pandemic. J Am Coll Emerg Physicians Open. 2021;2(1) doi: 10.1002/emp2.12349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Muselli M., Cofini V., Mammarella L., Carmignani C., Fabiani L., Desideri G., et al. The impact of covid-19 pandemic on emergency services. Ann di Ig: Med Prev e di comunita. 2021 doi: 10.7416/ai.2021.2480. [DOI] [PubMed] [Google Scholar]
  • 35.Metzler B., Siostrzonek P., Binder R.K., Bauer A., Reinstadler S.J. Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage. Eur Heart J. 2020;41(19):1852–1853. doi: 10.1093/eurheartj/ehaa314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Kim W., Jung T.Y., Roth S., Um W., Kim C. Management of the COVID-19 pandemic in the republic of korea from the perspective of governance and public-private partnership. Yonsei Med J. 2021;62(9):777. doi: 10.3349/ymj.2021.62.9.777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Kim K.H., Tandi T.E., Choi J.W., Moon J.M., Kim M.S. Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications. J Hosp Infect. 2017;95(2):207–213. doi: 10.1016/j.jhin.2016.10.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Lee H., Lee J.R., Jung H., Lee J.Y. Power of universal health coverage in the era of COVID-19: a nationwide observational study. Lancet Reg Health West Pac. 2021;7 doi: 10.1016/j.lanwpc.2020.100088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Webb Hooper M., Napoles A.M., Perez-Stable E.J. COVID-19 and racial/ethnic disparities. Jama. 2020 doi: 10.1001/jama.2020.8598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Mongin D., Cullati S., Kelly-Irving M., Rosselet M., Regard S., Courvoisier D.S.: Neighbourhood socio-economic vulnerability and access to COVID-19 healthcare during the first two waves of the pandemic in Geneva, Switzerland: A gender perspective. eClinicalMedicine 2022, 46:101352. [DOI] [PMC free article] [PubMed]
  • 41.Nguyen D.L., Ambinder E.B., Myers K.S., Oluyemi E. Addressing disparities related to access of multimodality breast imaging services before and during the COVID-19 pandemic. Acad Radiol. 2022 doi: 10.1016/j.acra.2022.03.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Splinter M.J., Velek P., Ikram M.K., Kieboom B.C.T., Peeters R.P., Bindels P.J.E., et al. Prevalence and determinants of healthcare avoidance during the COVID-19 pandemic: a population-based cross-sectional study. PLoS Med. 2021;18(11) doi: 10.1371/journal.pmed.1003854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Krueger P.M., Chang V.W. Being poor and coping with stress: health behaviors and the risk of death. Am J Public Health. 2008;98(5):889–896. doi: 10.2105/AJPH.2007.114454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Choi S.H., Stommel M., Ling J., Noonan D., Chung J. The impact of smoking and multiple health behaviors on all-cause mortality. Behav Med. 2020:1–8. doi: 10.1080/08964289.2020.1796570. [DOI] [PubMed] [Google Scholar]
  • 45.Alexander G.C., Tajanlangit M., Heyward J., Mansour O., Qato D.M., Stafford R.S. Use and content of primary care office-based vs telemedicine care visits during the COVID-19 pandemic in the US. JAMA Netw Open. 2020;3(10) doi: 10.1001/jamanetworkopen.2020.21476. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Infection and Public Health are provided here courtesy of Elsevier

RESOURCES